East West Pharma participates in the 13ᵗʰ Annual JPEF Global Diabetes Convention
East West Pharma participated in the 13ᵗʰ Annual Global Diabetes Convention organized by Jothydev’s Professional Education Forum (JPEF)—an event that continues to shape scientific discourse in the field of diabetology. Held at the picturesque Uday Samudra Beach Resort in Kovalam between July 11- July13, this three-day convention brought together leading diabetologists, endocrinologists, and researchers from across the country. This year’s theme, “Wait Matters,” eloquently emphasized the dual responsibility in diabetes care—urging clinicians to avoid diagnostic and therapeutic delays, while also recognizing the clinical importance of weight management.
As one of the proud exhibitors, East West Pharma marked its presence through an engaging display at Lobby Stall D, showcasing our growing diabetology portfolio. Our participation was aimed at Showcasing our evolving range of diabetes-focused therapies that address the real-world needs of Indian patients and engaging with healthcare professionals to foster dialogue on clinical experiences and unmet therapeutic challenges. East West Pharma took the initiative and independently facilitated the attendance of around 100 practicing doctors
The convention witnessed the convergence of around 1700 delegates and our stall had a footfall of 250 delegates. Apart from this, there were innumerable number of peripheral interactions that occurred on the fringes of formal discussions. Our Joint Managing Director himself got involved in these discussions that happened on the sidelines of the convention. These engagements reaffirm our belief in staying closely aligned with the frontline practitioners of diabetes care.
We sincerely thank Dr. Jothydev and the JPEF organizing committee for curating an exceptional scientific program and for providing East West Pharma the opportunity to contribute to this important dialogue on diabetes. Our presence at JPEF 2025 reflects our strategic commitment to strengthening our position in the diabetology segment. We look forward to building upon the connections made at this convention, deepening scientific collaborations, and continuing our efforts to shape a healthier tomorrow.
